We injected PPARα agonists into DCM + AAV9-GDF11 and DCM + AAV9-NC group mice (Fig. 6A) and found that the activation of PPARα exacerbated DCM and inhibited the protective effect of GDF11 against DCM. Here, PPARA is linked to familial dilated cardiomyopathy.